GEMFIBROZIL vs PRALUENT

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. GEMFIBROZIL and PRALUENT are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	GEMFIBROZIL	PRALUENT
Rating	70/100	70/100
Pharmacy pays	~$3.09 /30	—
Type	RX	RX
Active ingredient	GEMFIBROZIL	ALIROCUMAB
Manufacturer	Cadila Pharms Ltd	Regeneron Pharmaceuticals
Dosage forms	Tablet	Injectable
Drug class	Peroxisome Proliferator Receptor Alpha Agonist	—
Boxed warning	None	None
Treats	Coronary Artery Disease, Hypercholesterolemia, Hyperlipoproteinemias	Hypercholesterolemia, Atherosclerosis

gemfibrozil praluent

Rating

70/100

Pharmacy pays

~$3.09 /30

—

Type

Active ingredient

GEMFIBROZIL

ALIROCUMAB

Manufacturer

Cadila Pharms Ltd

Regeneron Pharmaceuticals

Dosage forms

Tablet

Injectable

Drug class

Peroxisome Proliferator Receptor Alpha Agonist

—

Boxed warning

None

Treats

Coronary Artery Disease, Hypercholesterolemia, Hyperlipoproteinemias

Hypercholesterolemia, Atherosclerosis

Frequently asked questions

Which is better-rated, Gemfibrozil or Praluent?

Gemfibrozil and Praluent are tied at 3.5 out of 5 by our independent rating.

What is the difference between Gemfibrozil and Praluent?

Gemfibrozil contains Gemfibrozil, while Praluent contains Alirocumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.